Cosmo Chem (005420) fair value: what the stock is really worth
As of Sep 23, 2026: fair value of Cosmo Chem KRW 22,714, price KRW 10,280, upside +121.0%, quality 37 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Cosmo Chem for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range 7,990 KRW – 87,688 KRW · fair‑value band 16,830 KRW – 28,892 KRW · the 10,280 KRW price screens below the 22,714 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Follow Cosmo Chem in your weekly email
Every Wednesday you see whether Cosmo Chem is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Cosmo Chemical Co., Ltd., a chemical materials company, manufactures and sells titanium dioxide (TiO2) anatase in South Korea.
Show more
Cosmo Chemical Co., Ltd., a chemical materials company, manufactures and sells titanium dioxide (TiO2) anatase in South Korea. The company offers COTIOX KA-100, a general purpose TiO2 anatase product for use in various applications, including rubbers, paints, papers, resins, etc.; and COTIOX KA-300, a TiO2 anatase product used in textiles comprising polyester filament, stable, and acryl fibers, as well as for use in plastics, inks, etc. It also provides ferrous sulfate heptahydrate for use in waste treatment agents, other raw materials, and catalysts; poly ferric sulfate solution, which is used as a waste treatment agent for dyeing, leather, paper, foods, and other wastes; cobalt sulfate liquid and cobalt sulfate solid phase for use in lithium secondary batteries, paint drying materials, cobalt pigments, tire bonds, and others; and gypsum used in construction materials. In addition, the company offers textiles, food, and electronic products. The company was founded in 1968 and is headquartered in Seoul, South Korea.
Stock analysis
Cosmo Chem (005420) currently trades at 10,280 KRW, while our model-based Fair Value estimate is 22,714 KRW, implying the stock looks roughly 54.7% undervalued today.
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of 21,745 KRW per share, and 8 of the 10 models we run sit above the 10,280 KRW price.
Bear case: the Asset-Based group reads lowest at 3,839 KRW, and 2 of the 10 models stay below the price. Evidence for this calculation is low.
Scenario range: 16,830 KRW (bear) to 28,892 KRW (bull), the price of 10,280 KRW sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 37/100 (below-average quality), in the Basic Materials sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Cosmo Chem reported revenue of 664B KRW in FY2025 versus 513B KRW in FY2021, a compound +6.7%/yr. Reported net income was −30.3B KRW in FY2025.
Key figures
Market cap 394B KRW (≈ $290M) · P/S ratio 0.54 · Net margin −4.6% · Return on equity −5.0% · Return on assets (EBIT) 1.7% · Operating margin 3.3% · Revenue (TTM) 686B KRW · Revenue growth (YoY) +13.6%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 32 out of 100 (medium confidence).
What moves the price
The share trades about 51% below its 52-week high and 29% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −40% fair-value upside, at 121%, 005420 screens cheaper than that median.
Fair Value models
Bear 16,830 KRWFair Value 22,714 KRWBull 28,892 KRW
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.40/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
−11.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−2.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+13.3%
Start year 2020 (pandemic). Over 10 years: +10.3% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.4%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
1.4% (2020) → −2.4% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+3.3%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (South Korea: IMF forecast 2.1% a year to 2030, 2.1% from 2016 to 2025) that is about +1.2% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 713 stocks
Beats the industry median on 4/8 measures
A mixed picture versus its industry peers.
Valuation
Quality Score37 · Bottom 25%
Fair Value upside+121% · Top 25%
Profitability
Return on assets−1% · Bottom 25%
Net margin (TTM)−4% · Bottom 25%
Operating margin (TTM)3% · Below median
Growth and dividend
Revenue growth14% · Above median
Balance sheet
Debt / equity0.03× · Below median
Valuation Multiplesvs Specialty Chemicals median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Cosmo Chem Fair Value". https://www.fairvalue-calculator.com/stock/005420
Frequently asked questions
Is Cosmo Chem (005420) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 22,714 KRW versus a price of 10,280 KRW, about +121% upside (undervalued).
What is the fair value of 005420?
Our model-based fair value for Cosmo Chem is 22,714 KRW (as of Sep 24, 2026), built from audited fundamentals. The current price: 10,280 KRW.
What is the quality score of 005420?
Cosmo Chem has a Quality Score of 37/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Cosmo Chem (005420)?
Our model-based price target is the fair value of 22,714 KRW (as of Sep 24, 2026) from 10 valuation models. Cautious scenario 16,830 KRW, optimistic scenario 28,892 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Cosmo Chem stock forecast for 2026?
Our models put fair value at 22,714 KRW, about +121% upside versus a price of 10,280 KRW (undervalued). Cautious scenario 16,830 KRW, optimistic scenario 28,892 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Cosmo Chem (005420)?
Cosmo Chem reported trailing-twelve-month revenue of about 686B KRW (latest available figure, as of Sep 24, 2026).
What growth is priced into Cosmo Chem (005420)?
For today's price to be fair in a discounted-cash-flow model, Cosmo Chem would have to grow free cash flow by +3.3 % per year for five years (discount rate 11.7 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +13.3 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of 005420 use?
Our models discount Cosmo Chem at 11.7 %: a base by market capitalisation (micro), damped by beta 0.57, country premium for South Korea. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Cosmo Chem that is +3.3 % per year a year over ten years, using the same discount rate (11.7 %) and the same formula as our fair value.
How much growth has Cosmo Chem (005420) delivered so far?
Over the past 5 years revenue at Cosmo Chem grew +13.3 % a year. The price currently implies +3.3 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Cosmo Chem (005420) growing?
The median revenue growth in the sector is +3.3 % a year. That is the yardstick for the growth priced into Cosmo Chem (+3.3 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Cosmo Chem (005420)?
The free-cash-flow yield on the price is 16.90 %: that much free cash flow Cosmo Chem produces per unit of market value. When it exceeds the discount rate of our models (11.7 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Cosmo Chem (005420)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Cosmo Chem it is 22,714 KRW per share (as of Sep 24, 2026), against a price of 10,280 KRW. It is the blended result of 10 valuation models (cash flow, earnings, asset, dividend).
Is Cosmo Chem stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 005420 trades below its calculated fair value: price 10,280 KRW, fair value 22,714 KRW, a gap of about +121% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 005420?
No. The price is what the market pays today (10,280 KRW); the fair value is what the company's own numbers justify (22,714 KRW). For Cosmo Chem the two are 12,434 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Cosmo Chem worth?
The market values Cosmo Chem at about 394B KRW (market capitalisation, as of Sep 24, 2026). Per share that is 10,280 KRW; our models calculate a fair value of 22,714 KRW per share.
What do the bullish and bearish scenarios say about 005420?
Our models span a range for Cosmo Chem: cautious scenario 16,830 KRW, base 22,714 KRW, optimistic 28,892 KRW per share (as of Sep 24, 2026, price 10,280 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Cosmo Chem (005420)?
Balance-sheet figures for Cosmo Chem (as of Sep 24, 2026): return on equity −5.0%, debt of 0.03 per unit of equity. They feed the Quality Score of 37/100, which measures business quality independently of the share price.
How far is 005420 from its 52-week high?
Cosmo Chem trades at 10,280 KRW, about 51% below its 52-week high of 21,000 KRW and 29% above the low of 7,990 KRW (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of 22,714 KRW is for.
Which stocks are comparable to Cosmo Chem?
From the same area (Basic Materials) we also value Linde plc, The Sherwin-Williams Company, Ecolab Inc, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Cosmo Chem stock attractive at the current price?
The data as of Sep 24, 2026: price 10,280 KRW, calculated fair value 22,714 KRW (+121%), Quality Score 37/100, from 10 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 005420 calculated?
We run Cosmo Chem through 10 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 22,714 KRW, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. Cosmo Chem currently trades 121 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Cosmo Chem (005420)?
The closing price on Sep 23, 2026 was 10,280 KRW. Our model-based fair value is 22,714 KRW, about +121% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Cosmo Chem right now?
The large discount to fair value meets weak quality (37/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case (16,830 KRW). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Key figures of Cosmo Chem
How large is the market capitalisation of Cosmo Chem (005420)?
The market capitalisation of Cosmo Chem is 394B KRW (≈ $290M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Cosmo Chem (005420)?
The price-to-sales ratio of Cosmo Chem is 0.54 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of Cosmo Chem (005420)?
The net margin of Cosmo Chem is −4.6% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Cosmo Chem (005420)?
The return on equity (ROE) of Cosmo Chem is −5.0% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Cosmo Chem (005420)?
On an EBIT basis the return on assets of Cosmo Chem is 1.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Cosmo Chem (005420)?
The operating margin of Cosmo Chem is 3.3% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Cosmo Chem (005420)?
Revenue at Cosmo Chem is growing +13.6% versus a year earlier (3y avg −2.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Cosmo Chem (005420)?
Earnings per share at Cosmo Chem are growing +292% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Cosmo Chem (005420) carry?
The net debt of Cosmo Chem is 352B KRW (fiscal year 2025, ≈ 5.3 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Cosmo Chem in the live analysis
One click puts Cosmo Chem on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
